Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World StudyThomas B. Casale, Bradley E. Chipps, Allan T. Luskin et al.|The Journal of Allergy and Clinical Immunology In Practice|2018Cited by 277
Evidence for Chlamydia pneumoniae Infection in Steroid-Dependent AsthmaDavid L. Hahn, H Zeitz, Allan T. Luskin et al.|Annals of Allergy Asthma & Immunology|1998Cited by 80
“Real-world” effectiveness of daily controller medicine in children with mild persistent asthmaDon A. Bukstein, Avi J. Bernstein, Allan T. Luskin|Annals of Allergy Asthma & Immunology|2003Cited by 71
Administrative Claims Analysis of Asthma-Related Health Care Utilization for Patients Who Received Inhaled Corticosteroids With Either Montelukast or Salmeterol as Combination TherapyFelicia Allen‐Ramey, Leona E. Markson, Shiva G. Sajjan et al.|Journal of Managed Care Pharmacy|2006Cited by 34
The reality of adherence to rhinitis treatment: Identifying and overcoming the barriersDon A. Bukstein, Judith R. Farrar, Allan T. Luskin|Allergy and Asthma Proceedings|2011Cited by 33